Non-Expert Acquisition & Remote Expert Review of Screening Echocardiography Images From Child Health & AnteNatal Clinics (NEARER SCAN)
Rheumatic Heart Disease
About this trial
This is an interventional screening trial for Rheumatic Heart Disease focused on measuring Echocardiography, Task-sharing, Aboriginal and Torres Strait Islander Peoples, Pregnancy, Children, First Nation Peoples
Eligibility Criteria
Inclusion Criteria in Australia: Any child between the age of 5 - 20 years old living in the participating community Pregnant women at high risk for RHD undergoing antenatal appointments or a hospital admission will be invited to participate. High risk for RHD will be defined as being from an area where RHD all-age prevalence is >1/1000 RHD or acute rheumatic fever incidence >30/100,000 per year in 5-14-year-olds. For practical purposes, this means Aboriginal women living in urban, rural or remote communities in northern Australia, or immigrants from high-risk settings. Inclusion criteria for Timor-Leste: Any child between the age of 5-20 years old and any pregnant woman. Exclusion criteria for Australia and Timor-Leste: Women who are unable to consent due to physical, mental, or intellectual disability will be excluded. Women and children with known existing cardiac disease will NOT be excluded since evaluation of severity and change in severity during pregnancy will be tracked, and data will inform the calculation of prevalence.
Sites / Locations
Arms of the Study
Arm 1
Experimental
Intervention
Participant receiving echocardiography screening.